Elevance Health, Inc.
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.75+0.15 (+0.04%)
Close on Nov 3, 2026Market cap $89.73BP/E 18.4Yield –
Elevance Health Non-GAAP Adj: Transaction and Integration Related Costs by Quarter
Non-GAAP Adj: Transaction and Integration Related Costs (Pre-Tax) ($M)
Elevance Health Non-GAAP Adj: Transaction and Integration Related Costs: $42M in Q3 2026, down 14.3% from a year earlier.
Latest, Q3 2026
42
Period ended Sep 30, 2026
Change on a year earlier
-14.3%
49 in Q3 2025
History
30 quarters
Since Q2 2019
Sources
25
Documents cited below
Where the Q3 2026 figure comes from
“|| Transaction and integration related costs 1 | 42 | 49 | 133 | 182”
Source: 8-K ER (FY2026Q3, 2026-10-21) ↗
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Elevance Health Non-GAAP Adj: Transaction and Integration Related Costs ($M), quarterly Q2 2019–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/nongaap-adj-tx-integration
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.